Menu

• Ask a Health Expert about SOFT TISSUE DISORDER
• Post Your Side Effect related to SOFT TISSUE DISORDER
• SOFT TISSUE DISORDER and FDA Warnings
• SOFT TISSUE DISORDER in Patients Wiki
• Report SOFT TISSUE DISORDER in Drug Side Effect Survey

SOFT TISSUE DISORDER side effect

What is SOFT TISSUE DISORDER ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Kenalog Side Effects Report #5783185-4
Health Professional from UNITED STATES reported KENALOG problem on June 19, 2008. Female patient, 23 years of age, weighting 123.0 lb, was diagnosed with multiple allergies and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: soft tissue disorder, . KENALOG dosage: unknown. Patient died.

Fosamax Side Effects Report #5642517-8
FOSAMAX problem was reported by a Physician from UNITED STATES on Feb 27, 2008. Female patient, 51 years of age, was diagnosed with hysterectomy, osteoporosis prophylaxis and was treated with FOSAMAX. After drug was administered, patient experienced the following problems/side effects: osteomyelitis, osteonecrosis, soft tissue disorder, wound secretion, . FOSAMAX dosage: 70 MG/WEEK. During the same period patient was treated with PREMARIN. Patient was hospitalized. Patient recovered.

Fosamax Side Effects Report #5642519-1
Physician from UNITED STATES reported FOSAMAX problem on Feb 27, 2008. Female patient, 66 years of age, was diagnosed with osteoporosis and was treated with FOSAMAX. After drug was administered, patient experienced the following problems/side effects: osteomyelitis, osteonecrosis, soft tissue disorder, wound secretion, . FOSAMAX dosage: 70MG WEEKLY. During the same period patient was treated with ANTIBIOTICS, NARDIL, PRAVACHOL, NEXIUM, RESTORIL, FENTANYL TRANSDERMAL SYSTEM, OXYCODONE, PLAVIX. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5578158-0
ERLOTINIB problem was reported by a Physician from GERMANY on Dec 18, 2007. Male patient, 75 years of age, was diagnosed with bronchial carcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: pneumothorax, soft tissue disorder, . ERLOTINIB dosage: (100 MG, QD), ORAL. During the same period patient was treated with MORPHINE, PREDNISONE, NOVAMINSULFON, ZOMETA, DICODID, FORADIL, SPIRIVA. Patient was hospitalized. Patient recovered.


Avonex Side Effects Report #5379517-1
Consumer or non-health professional from UNITED STATES reported AVONEX problem on June 20, 2007. Female patient, 52 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: back disorder, fall, soft tissue disorder, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.

Avonex Side Effects Report #5379517-1
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2007. Female patient, 52 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: back disorder, fall, soft tissue disorder, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.

Topotecan Side Effects Report #5694405-9
Consumer or non-health professional from UNITED STATES reported TOPOTECAN problem on Apr 03, 2008. Female patient, weighting 149.7 lb, was treated with TOPOTECAN. After drug was administered, patient experienced the following problems/side effects: pain in extremity, pathological fracture, soft tissue disorder, spinal column stenosis, . TOPOTECAN dosage: 10.2 MG. During the same period patient was treated with LYRICA, PERCOCET. Patient was hospitalized. Patient recovered.

Neulasta Side Effects Report #5306315-7
NEULASTA problem was reported by a Pharmacist from UNITED STATES on Mar 28, 2007. Female patient, weighting 144.2 lb, was treated with NEULASTA. After drug was administered, patient experienced the following problems/side effects: muscular weakness, pseudomonal bacteraemia, soft tissue disorder, staphylococcal sepsis, . NEULASTA dosage: unknown. During the same period patient was treated with CYTOXAN, TAXOL. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5316320-2
Physician from UNITED STATES reported REVLIMID problem on Apr 24, 2007. Male patient, 61 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, multiple myeloma, soft tissue disorder, . REVLIMID dosage: 25 MG - 10MG, DAILY, ORAL. Patient died on 02/24/1945.